Clinical Guidelines for APL Treatment

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Therapeutic guidelines for treatment of patients with de novo APL to be used by every institution that wants to follow them. All patients who are reported may be retrospectively analyzed

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: PETHEMA Foundation
• Treatments: Idarubicin; Methotrexate

Criteria

Inclusion Criteria:

• Genetic diagnosis of acute promyelocytic leukemia

Exclusion Criteria:

• No exclusion criteria